StockData
JRSSOTCServices-HospitalsFiscal year ends December 31

JRSIS HEALTH CARE Corp

Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Dec 20, 2024
$0.01+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$1.10M
P/E (TTM)
–
Dividend yield
–

JRSIS HEALTH CARE Corp revenue by segment

By business segment

By product or service

RevenueQ3 24Q2 24Q1 24Q3 23Q2 23Q1 23Q1 21Q4 20Q3 20Q2 20Q1 20Q4 19% of revenueYoY
Goods sold to related parties [Member]$139.81K$103.18K$158.42K$251.79K$48.75K$156.57K––––––62.7%-44.5%
Total revenue from goods sold [Member]$139.81K$146.73K$158.82K$251.79K$258.90K$174.69K––––––62.7%-44.5%
Service rendered to related parties [Member]$83.11K$59.03K$111.67K$245.32K$78.50K$302.30K––––––37.3%-66.1%
Total revenue from service rendered [Member]$83.11K$450.67K$341.60K$245.57K$78.50K$302.30K––––––37.3%-66.2%
Goods sold directly to third parties [Member]$5.85K$43.55K$401–$210.15K$18.12K––––––2.6%–
Service rendered directly to third parties [Member]$1.99K$391.64K$229.93K$255––––––––0.9%+680.8%
Pharmaceuticals [Member]––––––––$2.46M$1.76M$1.84M$2.83M––
Patient services [Member]–––––––$9.34M$7.55M$5.26M$4.15M$5.73M––
Patient services [Member]––––––$5.56M$9.34M$7.55M$5.26M$4.15M$5.73M––
Pharmaceuticals [Member]––––––$1.76M–$2.46M$1.76M$1.84M–––

By region

From the segment and revenue-disaggregation notes of Jrsis Health Care's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.